Seaweed antioxidants show promise in preventing Parkinson’s disease

Nkar­ta hit the brakes on one of its lead pro­grams Thurs­day af­ter­noon, de­pri­or­i­tiz­ing a CAR-NK ther­a­py de­signed to treat an ag­gres­sive form of leukemia af­ter

Sev­er­al in­dus­try stake­hold­ers are ask­ing the FDA to stream­line its process­es for work­ing with spon­sors on com­plex and in­no­v­a­tive de­signs for clin­i­cal tri­als. The com­ments

In­cyte’s newest cam­paign for Opzelu­ra (rux­oli­tinib) en­cour­ages itchy pa­tients to “Reimag­ine Re­lief” as it works to carve out a niche in the crowd­ed eczema treat­ment